Associated Banc-Corp’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-409
Closed -$41K 342
2020
Q4
$41K Buy
409
+342
+510% +$36.2K ﹤0.01% 403
2020
Q3
$7K Hold
67
﹤0.01% 429
2020
Q2
$7K Buy
67
+9
+16% +$930 ﹤0.01% 415
2020
Q1
$5K Buy
+58
New +$5.46K ﹤0.01% 416

Other funds holding AZN

Associated Banc-Corp's AZN Position: Q1 2021 in Review

Associated Banc-Corp sold out of AstraZeneca (AZN) in Q1 2021, closing a stake of 409 shares — an estimated $41K sold.

Associated Banc-Corp first reported a position in AZN in Q1 2020 and held it in 4 quarters. The position peaked at $41K in Q4 2020. 756 funds tracked by Wall St. Rank hold AZN as of Q1 2021.

  • Associated Banc-Corp reported no remaining AstraZeneca position as of Q1 2021 after selling out during the quarter.
  • Associated Banc-Corp sold 409 AstraZeneca shares in Q1 2021, an estimated $41K.
  • Associated Banc-Corp first reported a position in AstraZeneca in Q1 2020 and held it in 4 quarters.
  • Associated Banc-Corp's AstraZeneca position peaked at $41K in Q4 2020.
  • 756 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2021.

Based on Associated Banc-Corp's 13F filing for Q1 2021, filed 5 May 2021.